You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graves'%20orbitopathy

Showing 1 - 25 of 159
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)

Completed
  • Graves Ophthalmopathy
  • Orbital radiotherapy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 7, 2023

Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

Completed
  • Graves Ophthalmopathy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 29, 2023

Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

Recruiting
  • Graves Ophthalmopathy
  • Hsinchu, Taiwan
  • +1 more
Dec 1, 2022

Graves Ophthalmopathy Trial in Pisa (Sirolimus)

Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Nov 2, 2022

Active Moderate to Severe Graves' Orbitopathy Trial (SHR-1314)

Not yet recruiting
  • Active Moderate to Severe Graves' Orbitopathy
  • (no location specified)
May 23, 2022

Sirolimus in Graves' Orbitopathy

Completed
  • Graves Ophthalmopathy
  • Pisa, PI, Italy
    Endocrinologia II
Apr 19, 2022

Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)

Recruiting
  • Graves Orbitopathy
  • rabbit anti-thymocyte globulin
  • Katowice, Silesia, Poland
    Department of Internal Medicine and Oncological Chemotherapy, Me
Jan 14, 2022

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Immunological Follow-up of Patients With Basedow's Orbitopathy

Completed
  • Graves Orbitopathy
    • Montpellier, France
      Uhmontpellier
    Jan 10, 2022

    Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)

    Not yet recruiting
    • Graves' Orbitopathy
    • Atorvastatin 20mg
    • Placebo
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology II
    Sep 8, 2021

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Miami, Florida
    • +1 more
    Oct 31, 2023

    Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

    Completed
    • Thyroid Associated Ophthalmopathy
    • Hypercholesterolemia
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology I and II
    Aug 12, 2021

    Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

    Completed
    • Thyroid Associated Orbitopathy
    • Cairo, Egypt
      Cairo University
    Jul 15, 2022

    Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Graves Orbitopathy
    • Essen, Germany
    • +6 more
    Jul 14, 2022

    Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

    Completed
    Has Results
    • Thyroid Eye Disease
    • Graves' Orbitopathy
    • Teprotumumab
    • Placebo
    • Beverly Hills, California
    • +13 more
    Jan 31, 2022

    Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

    Recruiting
    • Graves Ophthalmopathy
    • +2 more
    • Simvastatin 40mg
    • Malmö, Sweden
      Dpt. of Endocrinology, SUS Malmö
    Nov 17, 2021

    Clinical Activity of TAO Using Periocular Images Taken by

    Completed
    • Thyroid Eye Disease
    • taking periorbital selfie images using smartphones
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Feb 15, 2023

    Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

    Completed
    Has Results
    • Thyroid Eye Disease
    • Teprotumumab
    • Beverly Hills, California
    • +12 more
    Dec 9, 2021

    Genetics and Epigenetics of Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • No Intervention
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology I and II
    Jul 22, 2020

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Beverly Hills, California
    • +22 more
    Jan 30, 2023

    Heart Rhythm After Intravenous Methylprednisolone Administration

    Completed
    • Graves Disease
    • +5 more
    • Intravenous Methylprednisolone
    • (no location specified)
    May 13, 2020

    Thyroid Associated Ophthalmopathy Trial (Orbital radiotherapy, Methylprednisolone)

    Not yet recruiting
    • Thyroid Associated Ophthalmopathy
    • (no location specified)
    Mar 24, 2020

    Customized Multiple Orbital Wall Decompression for

    Recruiting
    • Thyroid Eye Disease
    • Modified multiple orbital wall decompression
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Nov 17, 2022

    Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)

    Not yet recruiting
    • Graves' Disease
    • Mycophenolate Mofetil, Oral, 250 Mg
    • methimazole, oral, 10mg
    • (no location specified)
    Sep 28, 2023

    Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -

    Terminated
    Has Results
    • Graves Ophthalmopathy
    • Otelixizumab - low dose
    • +5 more
    • Newcastle upon Tyne, United Kingdom
      GSK Investigational Site
    Oct 8, 2020